Day 7 (2023)
Our ongoing mission is to make life better for the millions of Americans living with headache disorders in our country. Founded in 2008, the AHDA is a 501(c)(6) nonprofit supported by member contributions and individual donors. We are proud to have never taken direct contributions from pharmaceutical companies. Members include organizations, medical providers, scientists, caregivers, and people living with headache disorders.
At AbbVie, we are committed to empowering people living with migraine disease. We advance science that enables health care providers to care for people impacted across the spectrum of migraine. Through education and partnerships with the migraine community, we strive to help those with migraine navigate barriers to care, access effective treatments and reduce the impact of migraine on their lives. To learn more, visit AbbVie.com.
Support the organizations who have chosen to support the Migraine World Summit by visiting our Digital Exhibit Hall. Help us keep this event free and learn more about those who are helping us reduce the global burden of migraine. View the Digital Exhibit Hall >>
Today's Interviews
Mindfulness for Migraine & Pain Relief
Mia T. Minen, MD, MPH, FAHS
Associate Professor, Department of Neurology
NYU Grossman School of Medicine
Is Migraine a Progressive Disease?
Fred Cohen, MD
Assistant Professor of Medicine and Neurology
Mount Sinai Headache and Facial Pain Center, Icahn School of Medicine
European Headache Treatment Update
Patricia Pozo-Rosich, MD, PhD
Head of Neurology Section
Vall d’Hebron Hospital and Institute of Research, Spain
Managing Migraine in the East
K. Ravishankar, MD
Specialist in Headache Medicine
The Headache and Migraine Clinic, Jaslok and Lilavati Hospitals; Mumbai, India
Purchase full access to the entire 2024 Summit. Includes:
- All expert interviews with separate audio (MP3) files & transcripts
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Guidelines
- And much more!
